The serum protein levels of the tPA–BDNF pathway are implicated in depression and antidepressant treatment

Jiang, H, Chen, S, Li, C, Lu, N, Yue, Y, Yin, Y, Zhang, Y, Zhi, X, Zhang, D, Yuan, Y·2017·Translational Psychiatry
DOI 10.1038/tp.2017.43

Cited by (148)

Items 101–148 of 148

  1. New Wine in an Old Bottle: tPA for Ischemic Stroke Management
    Ruining She, Jinwen Ge, Zhigang Mei · 2023 · Translational Stroke Research
  2. The impact of antipsoriatic treatment on serum pro‐BDNF, BDNF levels, depression, anxiety scores, and quality of life
    Hasan K. Aksoy, Tülin Ergun, Mustafa Akkіprіk, İrem Peker Eyüboğlu, Dilek Seçkin Gençosmanoğlu, Gülru Pemra Cöbek Ünalan, Hakan Yöney · 2021 · Dermatologic Therapy
  3. Association Between Depressive Symptoms and Serum Brain-Derived Neurotrophic Factor Levels in Patients With First-Episode and Drug-Naïve Schizophrenia
    Yuxuan Wu, Xiangdong Du, Ruchang Yang, Yan Yue, Ruijie Peng, Siqi Wu, Haitao Wang, Yue Zhou, Xiaojia Fang, Nian Yuan et al. · 2022 · Frontiers in Psychiatry
  4. Clinical Improvement in Depression and Cognitive Deficit Following Electroconvulsive Therapy
    Ahmad Mus’ab Ahmad Hariza, Mohd Heikal Mohd Yunus, Jaya Kumar Murthy, Suzaily binti Wahab · 2023 · Diagnostics
  5. Alterations of learning and memory are accompanied by alterations in the expression of 5-HT receptors, glucocorticoid receptor and brain-derived neurotrophic factor in different brain regions of an animal model of depression generated by neonatally male treatment with clomipramine in male rats
    Ofelia Limón‐Morales, Kenia Morales-Quintero, Marcela Arteaga‐Silva, Tania Molina‐Jiménez, Marco Antonio Cerbón, Herlinda Bonilla‐Jaime · 2023 · Behavioural Brain Research
  6. Peptide Mimetics: Fast‐Forward Look
    David Gurwitz · 2017 · Drug Development Research
  7. Behavioral defects and downregulation of hippocampal BDNF and nNOS expression in db/db mice did not improved by chronic TGF-β2 treatment
    Yuki Tomiga, Yasuki Higaki, Keizo Anzai, Hirokazu Takahashi · 2022 · Frontiers in Physiology
  8. Alcohol use disorder disrupts BDNF maturation via the PAI-1 pathway which could be reversible with abstinence
    Shouqing Liu, Xin’e Xie, Dandan Zhao, Nini Jin, Yongwei Hu, Weiping Wang, Xiaodong Luo, Gang Li, Zhirong Yang · 2024 · Scientific Reports
  9. Discovery and validation of CREB1 as a transcription target of icaritin: Implications for the treatment of depressive-like behavior
    Ling Gu, Lei Li, Huiying Xu, Yuyan Ling, Ruiting Ma, Meijuan Chen · 2025 · Brain Research Bulletin
  10. Escitalopram treatment ameliorates chronic immobilization stress-induced depressive behavior and cognitive deficits bymodulating BDNF expression in the hippocampus
    Shilpa Borehalli Mayegowda, Bhagya Venkanna Rao, Byrathnahalli Suryanarayana Rao Shankaranarayana Rao · 2024 · Journal of Applied Pharmaceutical Science
  11. Graph convolutional network with attention mechanism improve major depressive depression diagnosis based on plasma biomarkers and neuroimaging data
    Chaonan Jiang, Bo Lin, Xinyi Ye, Yiran Yu, Pengfeng Xu, Chenxu Peng, Tingting Mou, Xinjian Yu, Haoyang Zhao, Miaomiao Zhao et al. · 2024 · Journal of Affective Disorders
  12. Sex-dependent associations of serum BDNF, glycolipid metabolism and cognitive impairments in Parkinson’s disease with depression: a comprehensive analysis
    Xinxu Wang, Chi Zhou, Yanzhe Li, Hechao Yang, Xiaoxiao Sun, Shen Li, Jie Li · 2024 · Journal of Neural Transmission
  13. Intermediation of perceived stress between early trauma and plasma M/P ratio levels in obsessive-compulsive disorder patients
    Puyu Li, Jiayue Cheng, Qiumeng Gu, Pei Wang, Zhiguang Lin, Qing Fan, Jue Chen, Zhen Wang · 2021 · Journal of Affective Disorders
  14. Mechanism of Wuling powder modulating proBDNF/p75NTR/sortilin and BDNF/TrkB pathways in the treatment of ulcerative colitis complicated with depression
    Jing-Jing Wang, Yihong Fan, Wan-Ting Cao, Rong Huang, Xinyi Yao, Menglin Li · 2025 · World Journal of Gastroenterology
  15. The astrocytic sigma-1 receptor constitutes in the fast antidepressant action of hypidone hydrochloride (YL-0919) in rodents
    Jinfeng Li, Hai-Xia Chang, Jia-Ning Zhao, Jin-Hao Bao, Wei Dai, Yunfeng Li · 2025 · Frontiers in Pharmacology
  16. Magnesium Potentiates the Vortioxetine’s Effects on Physical Performances and Biological Changes in Exercise-Induced Stress in Rats
    Paula Alina Fotache, Liliana Mititelu-Tarțău, Mária Bogdán, Beatrice Rozalina Bucă, Liliana Lăcrămioara Pavel, Ana-Maria Pelin, Andreea-Daniela Meca, Cosmin Gabriel Tartau, T. Popa · 2022 · Medicina
  17. Hippocampal overexpression of tissue-type plasminogen activator “tPA” attenuates social defeat-induced depression and ethanol related behavior in mice
    Amine Bahí · 2025 · Alcohol
  18. Exosomal MYD88 isolated from 4T1 breast cancer cells using microfluidic chips promotes depressive-like behavior through neural remodeling in the mPFC
    Bin Zhou, Hanying Ma, Yunxiao Li, Ting He, Xu Yao, Bi‐Feng Liu, Jia Guo, Jiaping Zhang, Huiliang Zhang · 2025 · Brain Behavior and Immunity
  19. The Plasminogen Activation System in the Central Nervous System: Implications for Epilepsy and Neuropsychiatric Disorders
    Elena M. Suleymanova, Anna A. Karan · 2025 · International Journal of Molecular Sciences
  20. BDNF and GDNF in Parkinson’s Disease: Associations with Clinical Features, Disease Course, and Progression—A Systematic Review
    Julia Węgrzynek‐Gallina, Aleksandra Buczek, Jakub J. Malkiewicz, Tomasz Chmiela, Tomasz Gallina, Patrycja Hudzińska, Joanna S. Siuda · 2026 · Molecular Neurobiology
  21. Significance of non-motor symptoms and development of a screening tool for osteoporosis in Parkinson's disease
    Fang Zhang, Jianjun Lu, Yong Zhang, Jiawen Liu · 2024 · Clinical Neurology and Neurosurgery
  22. Region-Specific Long-Term Transcriptional Changes in the Plasminogen Activation System and Neuroinflammation in the Rat Brain After Status Epilepticus: Association with Depressive-like Behavior
    Anna A. Karan, Elizaveta Selivanova, Yulia S. Spivak, Elena M. Suleymanova · 2025 · Brain Sciences
  23. Identification and Analyses of Crucial Genes Associated with Pathogenesis of Major Depressive Disorder
    Jiao Li, Qing Ma, Ming Ai · 2023 · Psychiatry and Clinical Psychopharmacology
  24. Moderation and Mediation Analysis of the Relationship between Total Protein Concentration and the Risk of Depressive Disorders in Older Adults with Function Dependence in Home Care
    Grzegorz Nowicki, Barbara Janina Ślusarska, Agnieszka Bartoszek, Katarzyna Kocka, Alina Deluga, Hanna Kachaniuk, Marta Łuczyk · 2018 · Nutrients
  25. Abnormal activation patterns in MT+ during visual motion perception in major depressive disorder
    Dong‐Yu Liu, Xiwen Hu, Jinfang Han, Zhong-Lin Tan, Xue Mei Song · 2024 · Frontiers in Psychiatry
  26. Neurotrophic Factors in Experimental Cerebral Acanthamoebiasis
    Natalia Łanocha-Arendarczyk, Karolina Kot, Irena Baranowska‐Bosiacka, Patrycja Kapczuk, Aleksandra Anna Łanocha, Danuta Izabela Kosik-Bogacka · 2022 · International Journal of Molecular Sciences
  27. Network pharmacology combined with experimental verification for exploring the potential antidepressant mechanism of Traditional Chinese Medicine Buyang Huanwu Decoction in lipopolysaccharide-induced depressed mouse model
    Sashuang Liu, Yihe Wang, Xinyu Zhou, Yijing Zhao, Zhen Wang, Dexiang Liu · 2025 · Brain Research
  28. Lumbrokinase modulates tissue plasminogen activator and alleviates behavioral and cognitive deficits in mice with chronic social defeat stress
    Vichuda Charoensaensuk, Bor‐Ren Huang, Shiang‐Suo Huang, Cheng‐Fang Tsai, Yen-Chang Chen, Chia-Yu Lin, Chingju Lin, Han-Tsung Cheng, Chao-Wei Chen, Yu-Wen Wang et al. · 2026 · Biomedicine & Pharmacotherapy
  29. Efficacy and safety of estradiol/dydrogesterone combined with escitalopram in the treatment of anxiety and depression in perimenopausal women: a randomized controlled trial
    Shufang Wu, Guiying Zeng, Saisai Chen, Hongbin Chen, Senpei Xie, Jiabao Zhang, Yingchun Xiao, Nan Liu, Hui Chen, Ronghua Chen · 2026 · Frontiers in Physiology
  30. Receptor tyrosine kinases in major depressive disorder
    Fatima Dakroub, Youmna El-Orfali, Sarah Mantash, Habib Alkalamouni, Rayan Dakroub, Firas H. Kobeissy · 2023 · Elsevier eBooks
  31. The Effects of Blood Flow Restriction Exercise on Muscle–Brain Crosstalk: A Systematic Review
    Josh B. Landers, Korben R. Landers, Nicholas G. Young · 2025 · Muscles
  32. Association between plasma dipeptidyl peptidase-4 activity to brain-derived neurotrophic factor ratio and depressive symptoms in middle-aged and older adults with normal glucose tolerance: A cross-sectional study
    Tianpeng Zheng, Xu Chen, Bo Ge, Bo Chen, Linyuan Qin, Li Tian, Yun Gao, Xueping Hu, Liuping Xiao, Haidong Pan et al. · 2020 · The World Journal of Biological Psychiatry
  33. The combination of serum BDNF, cortisol and IFN-gamma can effectively diagnose major depressive disorder
    Suzhen Chen, Yuqun Zhang, Yonggui Yuan · 2021 · Research Square
  34. The level of neurotrophins in the brain of mice with urokinase gene knockout in experimental melanoma and comorbid pathology
    Elena Mikhaylovna Frantsiyants, Irina Viktorovna Kaplieva, Valeriya Akhtyamovna Bandovkina, Ekaterina Igorevna Surikova, Irina Valer'evna Neskubina, Natal'ya Dmitrievna Cheryarina, Lidiya Konstantinovna Trepitaki, Natalia S. Lesovaya, Власов Станислав Григорьевич, Луганская Роза Генриковна et al. · 2021 · The Scientific Notes of the Pavlov University
  35. A NETWORK PHARMACOLOGICAL INVESTIGATION INTO THE TREATMENT OF PERIMENOPAUSAL DEPRESSION WITH A WARMING AND TONIFYING KIDNEY-YANG RECIPE
    Yuchang Jiang, Zaili Gan, Mi Li, Yue Su, YONG JIANG, Yangzhi Peng · 2023 · Journal of Mechanics in Medicine and Biology
  36. Gero-protective Impact of Astaxanthin on Experimental Model of Brain Aging: Biochemical and Molecular Study
    Hanadi M. Baeissa, Aminah A. Barqawi, Manal Abdulbari Tashkandi, Leena M. Alqahtani, Reem S. Alazragi, Neveen A. Salem, Rasha Hamed Hussein · 2023 · Egyptian Journal of Chemistry
  37. Research Progress of Traditional Chinese Medicine in the Treatment of Depression based on Immune Inflammation
    2024
  38. RETRACTED: Experimental study on the effect of Mongolian medicine warming acupuncture on proBDNF-tPA-BDNF balance in depression rats based on thermal imaging monitoring
    A Runa, Qinglin Bao, Rigenjiya Mu, Muqile Te, Yin Chaoketu Sai, Rilebagen Hu, Rentuya Sa, Lengge Si, A Gula · 2024 · Thermal Science and Engineering Progress · Retracted
  39. Coenzyme-Q10 diminishes early behavior indicative of depressive-like phenotype induced by overweight in a murine model of litter size reduction
    Carolina Soares Horta de Souza, Fernando Vitor Vieira, Thais Da Silva Maciel, Viviana Carolina Trujillo Rojas, Cíntia Onofra Novais, Sebastião Nilce Souto Filho, Alexandre Giusti‐Paiva, Tayllon dos Anjos‐Garcia, Bruna Kalil, Fabiana C. Vilela · 2025 · Brain Disorders
  40. Transforming growth factor-β superfamily members as potential biomarkers for adolescent major depressive disorder
    Xiaolan Wang, Yiting Kong, Junjie Xiang, Zhenghao Jiang, Yijia Wang, Xiaorong Chen, Liyang Wan, Su Ling Hong, Li Kuang · 2025 · Frontiers in Psychiatry
  41. Association of exercise type and levels with depressive symptoms in a Korean population
    Jae Ho Park, Joong-Yeon Lim, Hyun‐Young Park · 2025 · BMC Sports Science Medicine and Rehabilitation
  42. Evaluation of serum GDNF, TIMP4, and tPA levels in generalized anxiety disorder: a case–control study
    Provati Karmakar, MMA Shalahuddin Qusar, Md. Rabiul Islam · 2026 · Beni-Suef University Journal of Basic and Applied Sciences
  43. Progress on the neurotrophic effects of antidepressant drugs
    Pan Jing, Xi-Cheng Liu, Xiao-Peng Yin, Ye Fu, Qing Tian, Xiao-Bin Zhang · 2026 · World Journal of Psychiatry
  44. Stress-induced plasminogen activator inhibitor-1 (PAI-1) as a blood biomarker and brain risk factor for PTSD
    Marie Mennesson, S. Abdelkaoui, Valérie Roullot, Sophie Tronel, Adeline Cathala, Valérie Lalanne, Pierre‐Louis Raux, Leila Makrini, Emmanuel Valjent, Anaïs M. Duffaud et al. · 2026 · Molecular Psychiatry
  45. Trafic neuronal de l’activateur tissulaire du plasminogène (tPA)
    Sophie Lenoir · 2018 · theses.fr (ABES)
  46. Neurotoxicité précoce et mécanismes de neuroprotection dans des modèles poisson‐zèbre de tauopathies
    Clément Barbereau · 2020 · theses.fr (ABES)
  47. Vascular consequences of antidepressant use: Balancing neuropsychiatric benefits and hemostatic risks
    Shu Yu, J J Li, Yaoyang Fu · 2026 · Asian Journal of Psychiatry
  48. Exercise modulation of BDNF/TrkB signaling in Parkinson’s disease: an evidence-calibrated review of neuroprotective mechanisms, biomarker limitations, and translational gaps
    Chuan Chen, Kaihua Liu, Meng Xiang, Xueqin Zhang · 2026 · Frontiers in Neurology